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Myogenic regulatory factorThe process of muscle cell differentiation into myotubes, termed myogenesis, depends on a complex
coordination of myogenic factors, many of which are regulated post-transcriptionally. HuR, an mRNA-binding
protein, is responsible for regulating the expression of several such myogenic factors by stabilizing their
mRNAs. The critical role for HuR in myogenesis also involves the nucleocytoplasmic shuttling ability of this
protein. Indeed, in order to perform its stabilizing functions, HuR must accumulate in the cytoplasm. This
requires its dissociation from the import factor Transportin 2 (TRN2) which is actually caused by the cleavage
of a portion of cytoplasmic HuR. In this review, we describe the roles of HuR during myogenesis, and the
mechanisms regulating its cytoplasmic accumulation. This article is part of a Special Issue entitled: Regulation
of Signaling and Cellular Fate through Modulation of Nuclear Protein Import.element; AUBP, ARE-binding
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l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Post-transcriptional regulation of muscle cell differentiation
During mammalian development, mono-nucleated muscle cells,
myoblasts, must fuse to form multi-nucleated myotubes and then
myoﬁbers. This process is called myogenesis, and it is also crucial for
muscle repair and growth [1]. Given the clear importance of this
physiological event, mammals have evolved a tight regulatory system
to govern the onset of myogenesis. A variety of factors contribute to
this process, termed myogenic regulatory factors (MRFs), and their
expression has been clearly demonstrated to be tightly regulated
during the myogenic process [1–7]. In particular, many of the mRNAs
encoding for these MRFs contain destabilizing elements in their 3′
untranslated region (3′UTR). These include A/U repeats as well as G/U
rich elements, called A/U-rich elements (AREs) and GREs, respectively
[8–11]. GRE- and ARE-containing mRNAs are susceptible to enhanced
decay, such as ARE-Mediated Decay (AMD) for ARE-containing
mRNAs, and are characterized by having short half-lives that govern
their protein expression levels [8,12,13]. This allows a tight control
over the time at which they are expressed, enabling the speciﬁc
activation of physiological processes such as myogenesis.Certain proteins have been shown to speciﬁcally bind these
elements. For example, a class of RNA-binding proteins, called ARE-
binding proteins (AUBP), is capable of recognizing ARE-containing
mRNAs. These AUBPs, however, can either assist in the decay process,
or can actually stabilize these messages, thus allowing their
expression [12–15]. To date, KSRP (KH-domain Splicing Regulatory
Protein) and HuR are the only AUBPs that have been shown to
modulate the expression of certain MRFs. KSRP has been shown to
bind and destabilize themRNAs of p21 andmyogenin, important MRFs
[16]. During muscle development however, KSRP is phosphorylated,
which leads to a loss of association with its pro-myogenic targets.
Other destabilizing factors have also been linked to myogenesis in an
ARE-independent manner. CUGBP1 was recently identiﬁed to bind
GREs and was implicated in the instability linked to these elements
[8]. Other RNA-decay systems, such as nonsense-mediated decay
(NMD) and Staufen1-mediated decay (SMD), are also involved in the
regulation of myogenesis, having been recognized to inﬂuence the
stability of myogenin mRNA [17–19]. While the implication of KSRP,
CUGBP1 and Staufen1 seems to be important for proper regulation of
myogenesis, very little is known about the molecular mechanisms
regulating their actions during this process.
HuR, however, is a well-characterized stabilizing AUBP, the
regulation of which is better understood in myogenesis. HuR is a
ubiquitously expressedprotein of the ELAV-1 family (embryonic lethal
abnormal vision in Drosophila) which transports ARE-containing
messages from the nucleus to the cytoplasm [12,13,20–23]. Once in
the cytoplasm, HuR regulates mRNA expression by either stabilizing
messages, or inﬂuencing their translation. While HuR has an
abundance of mRNA targets involved in various cellular processes
including cell-cycle regulation and stress-response, several
myogenic factors have been identiﬁed to be regulated by HuR. These
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Myogenesis also requires that the post-transcriptional regulation of
certainmRNAs byHuRbe interrupted. Thiswas recently demonstrated
when it was shown that the mRNA level and stability of the cell-cycle
control factor Ccnd1/Cyclin D1 is reduced duringmyogenesis [24]. This
result was not particularly surprising, since muscle cell differentiation
requires that myoblasts undergo cell-cycle arrest [1]. Gherzi et al.
demonstrated that the HuR-stabilizing complex loses association from
Ccnd1 mRNA during the differentiation of murine myoblast cells
(C2C12), causing the destabilization of this mRNA and a reduction in
its protein expression. Thus, beyond promoting the expression of pro-
myogenic MRFs, HuR also contributes to halting unwanted processes.
Together, these observations have clearly established a role for HuR in
myogenesis, further supported by the fact that an absence of HuR
prevents this process [9–11,25]. Therefore, this review focuses on the
HuR-mediated control of myogenesis, with particular emphasis on
how HuR localization impacts this important process.2. Cytoplasmic HuR is crucial for myogenesis
Characterization of how HuR regulates myogenesis led to the
observation that the cytoplasmic localization of HuR is required in
order for it to execute its pro-myogenic function [9,10]. The ability of
HuR to trafﬁc between the nuclear and cytoplasmic compartments is
mediated by the HNS (HuR Nucleocytoplasmic Shuttling) motif. This
motif modulates the localization of HuR through interactions with
protein partners. Generally, the stabilizing function of HuR has been
shown to correlate with its cytoplasmic localization [11,12,14,15].
Indeed, if HuR is sequestered to the nucleus, known mRNA targets of
HuR have been shown to have a reduced half-life [26]. This was
recently demonstrated during inﬂammation, where the phosphory-
lation of HuR and its cytoplasmic localization were reduced by
interleukin-19 (IL-19). The phosphorylation status of HuR was
previously reported to regulate the localization of this mRNA-binding
protein. Several phosphorylation sites for HuR have been identiﬁed,
and they do not all have the same inﬂuence on HuR localization. PKCα
phosphorylation at S158 and S221 causes HuR to accumulate in the
cytoplasm [27], whereas Cdk1 phosphorylation of HuR at S202 causes
it to be retained in the nucleus [28]. In the study by Cuneo et al., PKCα
activity was inhibited by IL-19, preventing HuR from localizing to the
cytoplasm, and thus reducing its mRNA stabilizing effect. While these
studies have been useful in understanding the general mechanisms
regulating HuR localization, they have not speciﬁcally looked at the
mechanisms behind the shuttling abilities of HuR during myogenesis.
The localization of HuR has been shown to involve both CRM1-
dependent and -independent pathways [21–23,29]. Through binding
to proteins containing a Nuclear Export Signal (NES), HuR, via CRM1,
can move to the cytoplasm. These protein partners include pp32/
PHAPI and APRIL/PHAPII [21,29]. Also responsible for nuclear import
of HuR are Transportin 1 (TRN1) and Transportin 2 (TRN2) proteins
[30,31]. Interference with these pathways has allowed the character-
ization of HuR localization in different cell systems [12,13,20–23,29].
During myogenesis, one intriguing observation was the speciﬁc
involvement of TRN2 in regulating the cytoplasmic accumulation of
HuR [11]. Indeed, the siRNA-mediated knockdown of TRN2 enhances
the cytoplasmic accumulation of HuR, thus enhancing muscle cell
differentiation. These ﬁndings were supported when the short, cell-
permeable antennapedia peptide (AP, which allows the uptake of
proteins with a N90% efﬁciency) was conjugated to the nucleocyto-
plasmic shuttling domain of HuR (HNS) and was added to myoblast
cells undergoing muscle differentiation [10]. This AP–HNS fusion
peptide proved to be capable of competing with HuR for binding to
TRN2, thus preventing the import of HuR into the nucleus. The
consequence of this, the cytoplasmic accumulation of HuR, enhanced
myogenesis [11].In this study, we also discovered that the inhibition of the TRN2/
HuR interaction is reﬂective of the cellular mechanisms which occur
during differentiation. As myogenesis progresses, the HuR and TRN2
interaction is lost, which correlates with the cytoplasmic accumula-
tion of HuR, and an increase in the stability of HuR pro-myogenic
mRNA targetsmyogenin andMyoD [11]. It was only recently, however,
that the cellular mechanism responsible for this interruption in HuR/
TRN2 was deciphered [25], described below.
3. Implication of caspase-mediated cleavage products of HuR in
muscle ﬁber formation
3.1. HuR cleavage regulates its cytoplasmic accumulation
During myogenesis, it has been shown that proteolytic enzymes,
called caspases, are activated [32,33].While caspases are best known for
their role in apoptotic cell death [34,35], data from several groups have
indicated that during muscle cell differentiation they exercise an
essential non-apoptotic function leading to muscle ﬁber formation
[32,33]. HuR was previously shown to be cleaved by caspases-3 and -7
during apoptotic cell death [36,37], and so it was not completely
surprising to ﬁnd that during myogenesis, when caspase-3 is activated,
HuR cleavage also occurs [25]. This cleavage produces twoHuR cleavage
products (24 kDa HuR-CP1 and 8 kDa HuR-CP2) and occurs at Asp 226
of HuR, dividing the HNS between the two fragments. Of the 3 RNA
Recognition Motifs (RRMs) of HuR, the ﬁrst two (RRM1 and RRM2) are
contained in HuR-CP1, while the C-terminal RRM3 is a part of HuR-CP2
[36].
In stress-response, where cleavage was ﬁrst discovered, we noted
that the cleavage products have different abilities to interact with the
protein partners of HuR. Speciﬁcally, HuR-CP2, but not -CP1, was
found to associate with pp32/PHAPI [36]. This was not particularly
surprising given that the interaction between HuR and pp32/PHAPI
was previously shown to involve the HNS and 3rd RNA-recognition
motif (RRM3) of HuR [29].
The association of TRN2 with HuR is also mediated by the HNS.
Since the majority of the HNS is retained in HuR-CP1, we assessed the
ability for HuR-CP1 to bind with TRN2, in C2C12 cells. Importantly,
HuR-CP1 not only bound to TRN2, but was even able to compete off
HuR-binding to TRN2 in an in vitro binding assay [25]. This is in
contrast to HuR-CP2, which does not bind TRN2.
These observations raised the possibility that the generation of HuR-
CP1, which we also identiﬁed to occur in vivo in a mouse muscle-
regeneration model [25], could be responsible for the interruption of
HuR/TRN2 binding thatwas previously reported to occur duringmuscle
cell differentiation [11]. Overexpression of HuR-CP1 triggered the
cytoplasmic accumulation of full-length HuR, as normally seen in
myogenesis, and also caused an increase in the stability of myogenin
mRNA [25]. This positive effect of HuR-CP1 on myogenesis was seen to
be indirect, however, dependent on the presence of full-length HuR.
Indeed, in the absence of full-length HuR, HuR-CP1 was unable to
induce differentiation, and also failed to rescue the mRNA level of
myogenin, which full-length HuR managed to achieve. These results
have thus shown that through its cleavage, HuR localization is auto-
regulated. By having HuR-CP1 bind TRN2 and thus block nuclear
re-import of full-length HuR, cytoplasmic accumulation of this RNA-
stabilizing factor occurs, which results in an increase in MRF mRNA
stability and production.
3.2. Non-cleavable HuR inhibits myogenesis
In order to determine the exact cleavage site of HuR, a non-
cleavable HuR point mutant was generated (HuR-D226A) [36]. This
mutant has been used to better understand the importance and
physiological signiﬁcance of HuR cleavage, and as such, was used to
Fig. 1. A non-cleavable mutant of HuR inhibits myogenesis. (A–B) Exponentially growing
C2C12 myoblasts (ATCC) were transfected with GFP, GFP-HuR or GFP-HuR-D226A, and
differentiation was then induced as previously described [10,11,25]. On day 3 of
differentiation, cells were ﬁxed and immunoﬂuorescence was performed [10] using an
antibody against myoglobin (DAKO). DAPI was used to stain nuclei. A single
representative ﬁeld for each cell treatment is shown. Bars, 20 μm. Controls for transfection
are available as Supplementary Fig. 1. The fusion index, shown in (B), was determined by
dividing the number of nuclei in myotubes by the total number of nuclei in a given
microscopic ﬁeld. Average valueswere graphed,with error bars representing the standard
error of themean (SEM) of three independent experiments. GraphPad software was used
to calculate signiﬁcance of the mean values using a one-way ANOVA analysis.
Fig. 2. Non-cleavable HuR interacts with TRN2. Total extracts from C2C12 cells
transfected with GFP-tagged HuR or HuR-D226A were collected 48 h after transfection
and were used for immunoprecipitation as previously described [25], with anti-TRN2
antibody [11], or IgG control (Jackson ImmunoResearch Laboratories), bound to protein
A sepharose beads (GE Healthcare). The immunoprecipitate (P) and the supernatant
(S) were analyzed by western blot [47] using 3A2 anti-HuR antibody [47]. The positions
of GFP-HuR and -HuR-D226A are indicated. Representative western blots of two
independent experiments are shown. HC stands for heavy chain of the antibody, and
asterisks indicate non-speciﬁc bands observed in the supernatants, but not in the
immunoprecipitates.
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stress response [25,36].
Following the knockdown of HuR, addition of HuR-D226A failed to
rescue physiological effects linked to HuR cleavage, that is, muscle
differentiation or apoptosis. Indeed, although AP-HuR can rescue the
differentiation of myoblasts in which HuR is knocked down, treating
these cells with AP-HuR-D226A did not yield the same effect [25]. The
same was seen for the induction of apoptosis following lethal stress in
HeLa cells [36]. In fact, non-cleavable HuR has the opposite effect on cell
death, that is, it inhibits apoptosis. Likewise, when GFP-HuR-D226A is
provided to C2C12 cells prior to the induction of differentiation,
myogenesis is signiﬁcantly reduced compared to GFP- or GFP-HuR-
treated muscle cells (Fig. 1). This indicates that a non-cleavable HuR
isoform can even act as a dominant negative mutant which inhibits
muscle cell differentiation.
One possible explanation for the dominant-negative effect of
HuR-D226A on apoptosis was proposed to depend on the binding ofHuR-D226Awith pp32/PHAPI. Since this protein partner of HuR is itself
involved in activating apoptosis [38–41], we speculated that perhaps by
not being cleaved, HuR-D226A sequesters pp32/PHAPI, thus preventing
it from executing its normal pro-death function [36]. Immunoprecip-
itation experiments demonstrated that HuR-D226A actually associates
4-fold more with pp32/PHAPI than wtHuR, supporting this hypothesis.
In muscle cells, however, the binding of wtHuR or HuR-D226A to TRN2
does not seem to be different. C2C12 cells, transfected with either GFP-
HuR or GFP-HuR-D226A were subjected to immunoprecipitation using
an anti-TRN2 antibody, and the association of each was assessed.While
both associated to TRN2, no notable difference could be seen between
HuR and theD226Adominant negative isoform (Fig. 2). It does however
appear that TRN2 plays an important role in the dominant-negative
effect of HuR-D226A onmuscle differentiation.When TRN2 levels were
reduced by siRNA in C2C12 cells and differentiation was induced, the
presence of HuR-D226A failed to inhibit differentiation (Fig. 3). This
indicates that HuR-D226A interferes with myogenesis through TRN2.
Given that the role of TRN2 in this process is to regulate the cytoplasmic
accumulation of full-lengthHuR, there are several possible explanations
for how HuR-D226A may be exercising its inhibitory effect. One
possibility is that HuR-D226A competes with endogenous HuR-CP1
for binding of TRN2, but it is also possible thatHuR-D226Amay compete
with HuR as a substrate for caspases, thus preventing the generation of
endogenousHuR-CP1. It is likely that the inhibitory effect ofHuR-D226A
acts early on duringmyogenesis, however, since addition of HuR-D226A
to cellswhichhave already formedmyotubeshadnoeffect (Fig. 4). Since
HuR-CP1 is generated only during the fusion step of myoblasts to
becomemyotubes, this observation suggests that HuR-D226A is unable
to disrupt the HuR-CP1/TRN2 complex. Therefore, it is possible that the
inhibitory effect of HuR-D226A on myoblast differentiation is due to its
ability to prevent the cleavage of endogenous HuR. Alternatively, HuR-
D226A may interfere with a HuR-independent function of TRN2 during
the early steps of myogenesis. This clearly indicates that further
characterizing the role of TRN2 and other components of the trafﬁcking
pathways in myogenesis will help delineate how protein and RNA
localization impact this essential process.4. Conclusion
It is important to note that the process of muscle cell differenti-
ation takes place over several days, and that the activation of caspases
Fig. 3. HuR-D226A acts as a dominant negative in a TRN2-dependentmanner. (A–C) C2C12
myoblasts were transfected with control siRNA (Ctr) or siRNA against TRN2 as previously
described [10,11,25], as illustrated in Supplemental Figure 2. The cells were then treated
twicewitheitherAP-GSTorAP-HuR-D226A-GST, 24 hprior to the initiationofdifferentiation
and again at the initiation of differentiation. AP-conjugated proteins were prepared and
added as described, at a 50-nM concentration [25]. (A) Phase-contrast pictures of a single
representative ﬁeld of view for each cell treatment on day 3 of differentiation are shown.
(B) Immunoﬂuorescence staining was performed on TRN2- or Ctr-siRNA-treatedmyoblasts
ﬁxed on day 3 of differentiation as described above. A single representative ﬁeld for each cell
treatment is shown. Bars, 20 μm. Fusion index, shown in (C), was evaluated and graphed as
described above, from three independent experiments, with error bars representing SEMs.
Two-way ANOVA analysis was performed using GraphPad software to determine
signiﬁcance of the differences, and the p-value shown is for the interaction of both variables.
Fig. 4. The inhibitory effect of non-cleavable HuR is no longer observed when cells are
treated on day 4 of myogenesis. (A–B) C2C12 cells induced for differentiation, and were
then treated with AP-conjugated GST or HuR-D226A 3 days later. The next day, these
cells were used for immunoﬂuorescence experiments with DAPI and the anti-
myoglobin antibody. A single representative ﬁeld for each treatment is shown. Bars,
20 μm. (B) The fusion index is shown, calculated as described above, with average
values graphed of two independent experiments.
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[9–11,25]. Endogenous HuR is cleaved, in vivo and in cultured murine
myoblasts, after day 2 of differentiation [25]. This corresponds to the
same time at which HuR loses association with TRN2, and when it
begins accumulating in the cytoplasm [11]. Our previous data clearly
showed that preventing the cleavage of HuR inhibits muscle cell
differentiation, while providing HuR-CP1, responsible for blocking the
TRN2-mediated import of full-length HuR, positively stabilizes the
HuRmRNA targetmyogenin, an important myogenic regulatory factor,
and enhances the myogenic process [25]. This raised the possibility
that either HuR-CP1, via its two RNA-binding domains (RRM1 and 2)
[36], directly participates in the stabilization of the myogenin mRNA,
or its pro-myogenic activity depends on the presence of wtHuR. Our
results have indicated that HuR-CP1 itself cannot rescue myogenesis
in the absence of full-length HuR [25], illustrating that the effect on
myogeninmRNA is indirect via HuR, and emphasizing the importance
of the remaining uncleaved cytoplasmic HuR in this process as a
regulator of gene expression for MRFs. This dependence on full-length
HuR to promote myogenesis, with a need for HuR-CP1 to trigger its
cytoplasmic accumulation, may also explain why in cells and in vivo,
only a fraction of total HuR is cleaved.
While the importance of HuR cleavage for muscle ﬁber formation
is now evident, the signals issued by myoblasts to trigger this effect
are unclear at this time. The importance of caspase-3 activation for
this process, and in myogenesis, has been shown [32,33], but the
upstream cascade responsible for this activation remains to be
determined. We recently uncovered the signalling pathway that
triggers HuR cleavage in response to stress stimuli, such as during
apoptosis, and this involves the stress-response kinase, PKR (protein
kinase dsRNA) [37]. Whether PKR is also involved in HuR cleavage
during myogenesis is still unknown. Intriguingly, PKR, by regulating
the p38MAPK and PI3K/Akt pathways, has been demonstrated to be
important for muscle differentiation. Indeed, PKR was shown to
strongly contribute to the ability of myoblasts to undergo myogenesis
1667C. von Roretz et al. / Biochimica et Biophysica Acta 1813 (2011) 1663–1667[42–44], and so it is possible that it may also be regulating HuR
cleavage in this system, in order to promote its myogenic function.
The increase in cytoplasmic distribution of HuR has also been
observed in cells undergoing stress. We previously showed that pp32/
PHAPI is necessary for this to occur [36], and as such, is likely responsible
for the nuclear export of HuR. It remains to be shown, however, if TRN2-
mediated import is blocked by HuR-CP1 in this system as well. Showing
such would provide a better understanding of how the HuR-CPs are
themselves important for the progression of cell death, an effect which
was previously shown [37]. It also remains to be seen if, and if so, how,
the HuR-CPs individually or collaboratively promote myogenesis.
The ability for HuR to post-transcriptionally regulate gene expres-
sion during myogenesis depends on its cytoplasmic accumulation, and
this occurs after a cascade of upstream events [9–11,25]. Naturally, this
sequence exerts a temporal control on the myogenic process, and this
explains in part the time needed for the progression of myogenesis.
Novel players which contribute to this process continue to be identiﬁed
[45,46], making it evident that the series of events leading to muscle
differentiation is complex. HuR is just one of many required compo-
nents, and though it was identiﬁed to play a crucial role in myogenesis
over seven years ago [9,10], with new attributes still being identiﬁed for
it such as its caspase-mediated cleavage, it is clear that this RNA-binding
protein still has some tricks up its sleeve.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2011.01.036.
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